Research programme: RNA targeting small molecule therapeutics - Integrated Biosciences
Latest Information Update: 03 Jun 2024
At a glance
- Originator Integrated Biosciences
- Class Anti-inflammatories; Small molecules
- Mechanism of Action RNA modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Unspecified
- Research Inflammation